bg
P

Phathom Pharma (PHAT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Phathom Pharma (PHAT)

Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more

  • USD9.08
  • USD9.43
  • USD8.96
  • USD17.02
  • -12.90%
  • 1M
  • 370.89k
  • 763.95k
  • 525M
  • 6.07
  • -10.80%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.